Darling Ingredients Inc. Common Stock vs DexCom, Inc. — how do they compare? Darling Ingredients Inc. Common Stock trades at $61.18 (market cap $9.82B), while DexCom, Inc. trades at $83.73 (market cap $31.86B). The key difference: DexCom, Inc. is far larger — about 3.2× Darling Ingredients Inc. Common Stock's market cap, and DexCom, Inc. is more actively traded (3,607,070 versus 2,815,184). Which is the better fit depends on your goals — on Pluang, investors hold Darling Ingredients Inc. Common Stock for 0 Days and DexCom, Inc. for 62 Days on average.
| DAR | DXCM | |
|---|---|---|
Market Cap | $9.82B | $31.86B |
Volume | 2,815,184 | 3,607,070 |
Sector | Consumer Staples | Health |
52-Week High | $68.34 | $92.34 |
52-Week Low | $29.91 | $54.84 |
Typical Hold Time | 0 Days | 62 Days |
Enterprise Value | $13.83B | $31.32B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
DexCom (DXCM) trades at $84.03, down 0.32% on the day, with strong fundamental performance including three consecutive quarterly EPS beats and robust 20.12% net income margin. The stock shows bearish technical signals with price near pivot point support at $84, while analyst consensus remains overwhelmingly positive with 81% buy ratings and $95.07 price target representing 13% upside potential. Recent news highlights expansion opportunities in Type 2 diabetes care and executive promotions.
DXCM presents a compelling growth story with expanding profit margins and consistent earnings outperformance, though technical weakness and premium valuation create near-term headwinds. The company's leadership in continuous glucose monitoring and Type 2 diabetes market expansion provide long-term catalysts, while competition and reimbursement risks require monitoring.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Darling Ingredients collects and processes used cooking oil, animal by-products, and food waste. It produces ingredients and renewable fuel feedstocks from these materials.
Read more on DAR →Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →